EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Identifying clinically relevant agranulocytosis in people registered on the UK clozapine Central Non-Rechallenge Database: retrospective cohort study

Ebenezer Oloyede iD, Christian J Bachmann iD, Olubanke Dzahini iD, Juan Miguel Lopez Alcaraz, Shaurya Dev Singh, Kalliopi Vallianatu, Burkhardt Funk, Eromona Whiskey iD, David Taylor iD

The British Journal of Psychiatry · 2024

DOI: 10.1192/bjp.2024.104 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The British Journal of Psychiatry, 2024. Verfasst von Ebenezer Oloyede und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Maudsley Hospital, London, UK. Hauptthemen laut MEDLINE: Clozapine, Agranulocytosis, Antipsychotic Agents, Databases, Factual. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clozapine is the most effective antipsychotic for treatment-resistant psychosis. However, clozapine is underutilised in part because of potential agranulocytosis. Accumulating evidence indicates that below-threshold haematological readings in isolation are not diagnostic of life-threatening clozapine-induced agranulocytosis (CIA).

Aims

To examine the prevalence and timing of CIA using different diagnostic criteria and to explore demographic differences of CIA in patients registered on the UK Central Non-Rechallenge Database (CNRD).

Method

We analysed data of all patients registered on the UK Clozaril ® Patient Monitoring Service Central Non-Rechallenge Database (at least one absolute neutrophil count (ANC) < 1.5 × 10 9 /L and/or white blood cell count < 3.0 × 10 9 /L) between May 2000 and February 2021. We calculated prevalence rates of agranulocytosis using threshold-based and pattern-based criteria, stratified by demographic factors (gender, age and ethnicity). Differences in epidemiology based on rechallenge status and clozapine indication were explored. The proportion of patients who recorded agranulocytosis from a normal ANC was explored.

Results

Of the 3029 patients registered on the CNRD with 283 726 blood measurements, 593 (19.6%) were determined to have threshold-based agranulocytosis and 348 (11.4%) pattern-based agranulocytosis. In the total sample (75 533), the prevalence of threshold-based agranulocytosis and pattern-based agranulocytosis was 0.8% and 0.5%, respectively. The median time to threshold-based agranulocytosis was 32 weeks (IQR 184) and 15 (IQR 170) weeks for pattern-based agranulocytosis. Among age groups, the prevalence of pattern-based agranulocytosis and threshold-based agranulocytosis was highest in the >48 age group. Prevalence rates were greatest for White (18%) and male individuals (13%), and lowest for Black individuals (0.1%). The proportion of people who were determined to have pattern-based agranulocytosis without passing through neutropenia was 70%.

Conclusions

Threshold-based definition of agranulocytosis may over-diagnose CIA. Monitoring schemes should take into consideration neutrophil patterns to correctly identify clinically relevant CIA. In marked contrast to previous studies, CIA occurred least in Black individuals and most in White individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineAgranulocytosisAntipsychotic AgentsDatabases, FactualHumansMaleFemaleAdultUnited KingdomMiddle AgedRetrospective StudiesPrevalenceYoung AdultAgedLeukocyte CountAdolescentPsychotic Disorders

Stichwörter der Autor:innen

Psychotic disorders/schizophreniaantipsychotics

Substanzen

ClozapineAntipsychotic Agents

Autor:innen und Institutionen

  • Pharmacy Department, Maudsley Hospital, London, UK.
  • Department of Psychiatry, University of Oxford, UK.
  • Department of Child and Adolescent Psychiatry, Ulm University, Germany.
  • Institute of Pharmaceutical Sciences, King's College London, UK.
  • AI4Health Division, Carl von Ossietzky Universität Oldenburg, Germany.
  • Institute of Information Science, Leuphana University, Lüneburg, Germany.

ORCID-Profile: Ebenezer Oloyede, Christian J Bachmann, Olubanke Dzahini, Eromona Whiskey, David Taylor

Zitieren

APA

Oloyede, E., Bachmann, C. J., Dzahini, O., Lopez Alcaraz, J. M., Singh, S. D., Vallianatu, K., Funk, B., Whiskey, E., & Taylor, D. (2024). Identifying clinically relevant agranulocytosis in people registered on the UK clozapine Central Non-Rechallenge Database: retrospective cohort study. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.2024.104

Vancouver

Oloyede E, Bachmann CJ, Dzahini O, Lopez Alcaraz JM, Singh SD, Vallianatu K, et al. Identifying clinically relevant agranulocytosis in people registered on the UK clozapine Central Non-Rechallenge Database: retrospective cohort study. The British Journal of Psychiatry. 2024. doi:10.1192/bjp.2024.104

BibTeX
@article{Oloyede2024,
  author = {Oloyede, Ebenezer and Bachmann, Christian J and Dzahini, Olubanke and Lopez Alcaraz, Juan Miguel and Singh, Shaurya Dev and Vallianatu, Kalliopi and Funk, Burkhardt and Whiskey, Eromona and Taylor, David},
  title = {Identifying clinically relevant agranulocytosis in people registered on the UK clozapine Central Non-Rechallenge Database: retrospective cohort study},
  journal = {The British Journal of Psychiatry},
  year = {2024},
  doi = {10.1192/bjp.2024.104}
}
Kostenlos starten →